Schadendorf, D., Lebbe, C., Amaral, T., Weide, B., Capone, M., Madonna, G., . . . Morello, S. Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy. BMJ Publishing Group.
Chicago Style (17th ed.) CitationSchadendorf, Dirk, et al. Serum CD73 Is a Prognostic Factor in Patients with Metastatic Melanoma and Is Associated with Response to Anti-PD-1 Therapy. BMJ Publishing Group.
MLA (9th ed.) CitationSchadendorf, Dirk, et al. Serum CD73 Is a Prognostic Factor in Patients with Metastatic Melanoma and Is Associated with Response to Anti-PD-1 Therapy. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.